Related Experiment Videos
[Digestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients]
Richard Montagnac1, Sylvie Méhaut, Francis Schillinger
1Service de nephrologie-hémodialyse, hôpital de Troyes, 101, avenue Anatole-France,10003 Troyes cedex, France. richard.montagnac@ch-troyes.fr
Abstract:
Administered to reduce hyperkaliema in patients with chronic renal failure, sodium polystyrene sulfonate (Kayexalate) can cause digestive complications. The most severe complication could be the intestinal necrosis or perforation. In the present report, we evoke these complications and illustrate them with some pictures from personal observations.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Chronic Kidney Disease III: Interprofessional Care
Peritoneal Dialysis III: Nursing Management
Antihypertensive Drugs: Potassium-Sparing Diuretics
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications